These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30849498)

  • 21. Ondansetron Use in Pregnancy.
    Siminerio LL; Bodnar LM; Venkataramanan R; Caritis SN
    Obstet Gynecol; 2016 May; 127(5):873-877. PubMed ID: 27054931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First trimester ondansetron exposure and risk of structural birth defects.
    Zambelli-Weiner A; Via C; Yuen M; Weiner DJ; Kirby RS
    Reprod Toxicol; 2019 Jan; 83():14-20. PubMed ID: 30385129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study.
    Sakran R; Shechtman S; Arnon J; Diav-Citrin O
    Reprod Toxicol; 2021 Jan; 99():9-14. PubMed ID: 33212170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of intravenous ondansetron for hyperemesis gravidarum.
    Sullivan CA; Johnson CA; Roach H; Martin RW; Stewart DK; Morrison JC
    Am J Obstet Gynecol; 1996 May; 174(5):1565-8. PubMed ID: 9065130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of abnormal pregnancy outcomes after using ondansetron during pregnancy: A systematic review and meta-analysis.
    Cao X; Sun M; Yang Q; Wang Q; Hou L; Wang J; Wu Y; Ge L
    Front Pharmacol; 2022; 13():951072. PubMed ID: 36120333
    [No Abstract]   [Full Text] [Related]  

  • 26. Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: A systematic review and meta-analysis.
    Acar S; Keskin-Arslan E; Erol-Coskun H; Kaya-Temiz T; Kaplan YC
    Reprod Toxicol; 2019 Apr; 85():65-74. PubMed ID: 30738954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations.
    Huybrechts KF; Hernandez-Diaz S; Straub L; Gray KJ; Zhu Y; Mogun H; Bateman BT
    JAMA; 2020 Jan; 323(4):372-374. PubMed ID: 31730152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of intractable hyperemesis gravidarum by ondansetron.
    Siu SS; Yip SK; Cheung CW; Lau TK
    Eur J Obstet Gynecol Reprod Biol; 2002 Oct; 105(1):73-4. PubMed ID: 12270570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ondansetron use during pregnancy: a case series.
    Ferreira E; Gillet M; Lelièvre J; Bussières JF
    J Popul Ther Clin Pharmacol; 2012; 19(1):e1-e10. PubMed ID: 22267256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
    Mayhall EA; Gray R; Lopes V; Matteson KA
    Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.
    Simino GP; Marra LP; Andrade EI; Acúrcio Fde A; Reis IA; De Araújo VE; Cherchiglia ML
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1183-94. PubMed ID: 27180992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade.
    Danielsson B; Webster WS; Ritchie HE
    Reprod Toxicol; 2018 Oct; 81():237-245. PubMed ID: 30149139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis.
    Yokoi A; Mihara T; Ka K; Goto T
    PLoS One; 2017; 12(10):e0186006. PubMed ID: 28977021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of ondansetron for spinal anesthesia during cesarean section: a meta-analysis of randomized trials.
    Zhou C; Zhu Y; Bao Z; Wang X; Liu Q
    J Int Med Res; 2018 Feb; 46(2):654-662. PubMed ID: 28856920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials.
    Gao C; Li B; Xu L; Lv F; Cao G; Wang H; Wang F; Wu G
    Drug Des Devel Ther; 2015; 9():2343-50. PubMed ID: 25960637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.
    Wu SJ; Xiong XZ; Lin YX; Cheng NS
    Surg Laparosc Endosc Percutan Tech; 2013 Feb; 23(1):79-87. PubMed ID: 23386158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence.
    Grigoriadis S; VonderPorten EH; Mamisashvili L; Roerecke M; Rehm J; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
    J Clin Psychiatry; 2013 Apr; 74(4):e293-308. PubMed ID: 23656855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials.
    del Giglio A; Soares HP; Caparroz C; Castro PC
    Cancer; 2000 Dec; 89(11):2301-8. PubMed ID: 11147601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ondansetron has similar clinical efficacy against both nausea and vomiting.
    Jokela RM; Cakmakkaya OS; Danzeisen O; Korttila KT; Kranke P; Malhotra A; Paura A; Radke OC; Sessler DI; Soikkeli A; Roewer N; Apfel CC
    Anaesthesia; 2009 Feb; 64(2):147-51. PubMed ID: 19143691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study.
    Ditto A; Morgante G; la Marca A; De Leo V
    Gynecol Obstet Invest; 1999; 48(4):232-6. PubMed ID: 10592423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.